APPULSE-PNH is a phase IIIB multicenter, single-arm, open-label study to evaluate the efficacy and safety of twice-daily oral Fabhalta monotherapy (200mg) in adults with PNH who were switched from ...

The list is sorted by stocks with the greatest percentage difference between valuation and price. Appulse Corp along with its subsidiaries is engaged in selling new and refurbished centrifuge machines ...

Novartis has reported positive topline outcomes from the multicentre Phase IIIB APPULSE-PNH trial of oral Fabhalta (iptacopan) for treating adults with paroxysmal nocturnal haemoglobinuria (PNH).

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A Month of Bright Planets Venus blazes at its brightest in the early evening, despite being only a slim crescent through the telescope eyepiece. Mars and Jupiter to rule the night sky after Venus ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.